Bolt Biotherapeutics, Inc.
BOLT
$5.32
$0.050.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 20.23% | 47.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.23% | 47.63% | |||
| Cost of Revenue | -12.84% | -18.45% | |||
| Gross Profit | 23.32% | 28.58% | |||
| SG&A Expenses | -5.09% | -8.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.37% | -17.42% | |||
| Operating Income | 16.36% | 23.98% | |||
| Income Before Tax | 16.55% | 22.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 16.55% | 22.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.55% | 22.45% | |||
| EBIT | 16.36% | 23.98% | |||
| EBITDA | 16.36% | 24.35% | |||
| EPS Basic | 16.63% | 22.48% | |||
| Normalized Basic EPS | 16.63% | 22.48% | |||
| EPS Diluted | 16.63% | 22.48% | |||
| Normalized Diluted EPS | 16.63% | 22.48% | |||
| Average Basic Shares Outstanding | 0.09% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.09% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||